Novo Nordisk's pricing strategies within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of value gouging, stating the stark distinction between U.S. costs and people in Europe and copyright.Scientific studies of Rybelsus and copyright have proven that both equally drugs are powerful for helpin